The global biosurgery market size is expected to reach $20.0 Billion By 2026 and growing at a CAGR 7 % over forecast period 2019 to 2026.
Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.
Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.
The report analyzes and forecasts the biosurgery market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global biosurgery market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the biosurgery market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of biosurgery market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part of the report preparation. Those reading the report will be able to get a detailed understanding about the market. Industry experts have verified and checked the data and information that have been taken from credible sources like websites, annual reports of companies, journals, and other resources. In order give the facts and data a pictorial form, diagrams, graphs, pie charts, and other representations have been used. That augments the visual appeal of the report and makes understanding it much easier.
Competitive Landscape is the most valuable part of this report
Some prominent market players are Johnson & Johnson (Ethicon); Medtronic Plc; Strykers; Baxter International Inc.; C.R. Bard; Sanofi; Pfizer; B. Braun Melsungen AG; and Integra lifeSciences Corporation. Most prominent players focus on new product launches, acquisitions, advancement in existing products and technologies, and other such strategies to expand their product portfolio and strengthen their market presence. For instance, in September 2018, Baxter international Inc., a global medical product company announced an agreement to acquire two sealant and hemostat products from Mallinckrodt plc. This agreement will enhance market share and product portfolio of the former.
Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market. This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.
Soft Tissue Attachments
Bone Graft Attachments
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are: